Diabetes

Atrasentan tied to lower risk for kidney events in T2DM with CKD

(HealthDay)—Atrasentan is associated with a reduced risk for renal events in patients with type 2 diabetes and chronic kidney disease, according to a study published online April 14 in The Lancet to coincide with the International ...